What is the address of Cabinet Médical Néphrologie Dossin?

The registered office of Cabinet Médical Néphrologie Dossin is located at Rue Bayard 17, 1420 Braine-l'Alleud.

Is Cabinet Médical Néphrologie Dossin still active?

Yes. According to the CBE (18 September 2026) Cabinet Médical Néphrologie Dossin is active, legal situation “Normale toestand”, started on 7 March 2019.

Is Cabinet Médical Néphrologie Dossin registered on Peppol?

No, Cabinet Médical Néphrologie Dossin is currently not registered on the Peppol network.

What is the enterprise number of Cabinet Médical Néphrologie Dossin?

The enterprise number of Cabinet Médical Néphrologie Dossin is BE0721963674.

When was Cabinet Médical Néphrologie Dossin founded?

Cabinet Médical Néphrologie Dossin was founded on 7 March 2019.

Who are the directors of Cabinet Médical Néphrologie Dossin?

According to the 2025 annual accounts, the directors of Cabinet Médical Néphrologie Dossin are: Thomas Jean-Paul DOSSIN.

Is Cabinet Médical Néphrologie Dossin a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 March 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Cabinet Médical Néphrologie Dossin make in 2025?

Cabinet Médical Néphrologie Dossin posted a profit after taxes of € 171,794 in financial year 2025.

What is the revenue of Cabinet Médical Néphrologie Dossin?

As a small company, Cabinet Médical Néphrologie Dossin is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 232,646.

Cabinet Médical Néphrologie Dossin (Private Limited)

Dossier Cabinet Médical Néphrologie Dossin, printed on 18 September 2026 from databakkes.be/en/0721963674/cabinet-medical-nephrologie-dossin. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Cabinet Médical Néphrologie Dossin from Braine-l'Alleud, company number BE0721963674, closed financial year 2025 with a result of € 171,794 after tax. For that financial year Cabinet Médical Néphrologie Dossin recorded a gross margin of € 232,646 and equity of € 52,144. Compared with financial year 2024, the result moved from € 156,899 to € 171,794. Profitable, and profit is growing. The buffer shrank hard: equity is 79 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 26, 2026.

What it is worth Shrank hard

€ 52,144

▼ 79% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 171,794

▲ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 281,554

▲ € 241,950 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 370,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 32,746

▼ 28% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 959

▼ 27% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 50,348

▲ 14% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 224,172 Gross margin 2022: € 224,172 First fiscal year in the series	€ 196,430 Gross margin 2023: € 196,430 ▼ 12% vs 2022 (€ 224,172) Unfavourable step	€ 213,907 Gross margin 2024: € 213,907 ▲ 9% vs 2023 (€ 196,430) Favourable step	€ 232,646 Gross margin 2025: € 232,646 ▲ 9% vs 2024 (€ 213,907) Favourable step	▲ 9%
Profit after taxes	€ 166,178 Profit after taxes 2022: € 166,178 First fiscal year in the series	€ 144,928 Profit after taxes 2023: € 144,928 ▼ 13% vs 2022 (€ 166,178) Unfavourable step	€ 156,899 Profit after taxes 2024: € 156,899 ▲ 8% vs 2023 (€ 144,928) Favourable step	€ 171,794 Profit after taxes 2025: € 171,794 ▲ 9% vs 2024 (€ 156,899) Favourable step	▲ 9%
Equity	€ 247,523 Equity 2022: € 247,523 First fiscal year in the series	€ 248,451 Equity 2023: € 248,451 Unchanged (€ 247,523) Favourable step	€ 250,350 Equity 2024: € 250,350 ▲ 1% vs 2023 (€ 248,451) Favourable step	€ 52,144 Equity 2025: € 52,144 ▼ 79% vs 2024 (€ 250,350) Unfavourable step	▼ 79%
Total debts	€ 288,235 Total debts 2022: € 288,235 First fiscal year in the series	€ 192,752 Total debts 2023: € 192,752 ▼ 33% vs 2022 (€ 288,235) Favourable step	€ 215,726 Total debts 2024: € 215,726 ▲ 12% vs 2023 (€ 192,752) Unfavourable step	€ 430,412 Total debts 2025: € 430,412 ▲ 100% vs 2024 (€ 215,726) Unfavourable step	▲ 100%
Cash	€ 332,834 Cash 2022: € 332,834 First fiscal year in the series	€ 265,373 Cash 2023: € 265,373 ▼ 20% vs 2022 (€ 332,834) Unfavourable step	€ 39,604 Cash 2024: € 39,604 ▼ 85% vs 2023 (€ 265,373) Unfavourable step	€ 281,554 Cash 2025: € 281,554 ▲ € 241,950 vs 2024 (€ 39,604) Favourable step	▲ € 241,950
Retained profit	€ 228,923 Retained profit 2022: € 228,923 First fiscal year in the series	€ 229,851 Retained profit 2023: € 229,851 Unchanged (€ 228,923) Favourable step	€ 231,750 Retained profit 2024: € 231,750 ▲ 1% vs 2023 (€ 229,851) Favourable step	€ 33,544 Retained profit 2025: € 33,544 ▼ 86% vs 2024 (€ 231,750) Unfavourable step	▼ 86%
Dividend	€ 225,000 Dividend 2022: € 225,000 First fiscal year in the series	€ 144,000 Dividend 2023: € 144,000 ▼ 36% vs 2022 (€ 225,000) Unchanged	€ 155,000 Dividend 2024: € 155,000 ▲ 8% vs 2023 (€ 144,000) Unchanged	€ 370,000 Dividend 2025: € 370,000 ▲ 139% vs 2024 (€ 155,000) Unchanged	▲ 139%
Balance sheet total	€ 535,758 Balance sheet total 2022: € 535,758 First fiscal year in the series	€ 441,203 Balance sheet total 2023: € 441,203 ▼ 18% vs 2022 (€ 535,758) Unchanged	€ 466,076 Balance sheet total 2024: € 466,076 ▲ 6% vs 2023 (€ 441,203) Unchanged	€ 482,556 Balance sheet total 2025: € 482,556 ▲ 4% vs 2024 (€ 466,076) Unchanged	▲ 4%

Key figures of Cabinet Médical Néphrologie Dossin, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Cabinet Médical Néphrologie Dossin?

What happened at Cabinet Médical Néphrologie Dossin in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 26, 2026 New annual accounts for financial year 2025: profit of € 171,794 (▲ 9% vs 2024). Source: NBB ↗
Mar 7, 2019 New establishment in Braine-l'Alleud. KBO
Mar 7, 2019 Start of the company according to the CBE. KBO

In short

From € 166,178 profit in 2022 to € 171,794 profit in 2025.

Paid € 190,606 in corporate taxes since 2022.

Best year ever: 2025, with € 171,794 profit.

Paid out € 894,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Cabinet Médical Néphrologie Dossin? We notify you, reason included.

Follow Cabinet Médical Néphrologie Dossin

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Thomas Jean-Paul DOSSIN

Cabinet Médical Néphrologie Dossin

Behind Cabinet Médical Néphrologie Dossin is Thomas Jean-Paul DOSSIN.

See the full network in the app

Directors

According to the 2025 annual accounts

Thomas Jean-Paul DOSSIN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Bayard 17

1420 Braine-l'Alleud

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0721.963.674
VAT number: BE 0721.963.674
Registered office: Rue Bayard 17, 1420 Braine-l'Alleud
Names & denominations: Cabinet Médical Néphrologie Dossin · CMN DOSSIN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 March 2019
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗